Supreme Court Fight Over Fish Oil Could Raise Prescription Drug Costs

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the way generic companies do business. This legal showdown highlights the ongoing tension between intellectual property rights and the need for affordable medications for the public. The outcome could set a precedent affecting the pricing of essential supplements and prescription drugs nationwide.